article thumbnail

Q2 2024 update: electronic medical record (emr) systems related private equity activity in the pharmaceutical industry

Pharmaceutical Technology

In the global pharmaceutical industry, there were 2 private equity deals announced in Q2 2024, worth a total value of $100m, according to GlobalData's Deals Database.

article thumbnail

Pharma Industry Townhall to be held in Mumbai

Express Pharma

The details are as follows: Event Date: March 16, 2024 Location: Radisson Blu Marol Andheri Time: 09:00 AM – 05:00 PM The event aims to equip professionals with the latest knowledge and strategies crucial for navigating the industry’s changing dynamics.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

When Worlds Collide: The Theory of Real-World Evidence Meets Reality

FDA Law Blog: Biosimilars

FDA believes that RWE has the power to “accelerate medical product development and bring new innovations and advances faster and more efficiently to the patients who need them, without compromising patient safety.” Every use of ESD is recorded, as is every behavior that falls within the intended use.

article thumbnail

Five Lessons Learned About Antimicrobial Stewardship Metrics

ID Stewardship

BCPS, BCIDP Article posted 13 December 2024 If you cannot measure it, you cannot determine if you have changedit. In this article an experienced antimicrobial stewardship pharmacist discusses lessons learned from navigating antimicrobial stewardship metrics. Authored by: Timothy P. Gauthier, Pharm.D.,

article thumbnail

European Health Data Space (EHDS) update: what this means for pharmaceutical and biotech

pharmaphorum

The intention is to streamline the process for patients wishing to access their medical records via electronic health record systems (“EHR systems”) and to facilitate the ability for researchers, innovators, and policy makers to use the data in a trusted and secure way that preserves privacy. When will it come into force?

article thumbnail

Part B reimbursement: earn revenue while saving time

PharmD Live

MIPS performance year 2022 (with payment year in 2024) offers fewer performance guard rails and exceptions–we’ve entered real-time quality improvement and performance measurement. They should provide technology to code and keep medical records for prompt reporting to CMS without introducing the stress of a steep technology learning curve.

article thumbnail

The case for AI and machine learning in life sciences

Pharmaceutical Technology

GlobalData forecasts that the market for AI platforms for the entire healthcare industry will reach $4.3bn by 2024, up from $1.5bn in 2019 [i]. For a detailed analysis and valuable insights into deploying successful NMT programs, download the paper below. [i]